Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04997304 · ClinicalTrials.gov registry record · Phase 4
Teva Asthma Predictive Analytics Study
A Phase 4 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT04997304 is a Phase 4 study that has completed, run by University of Michigan. The registered enrollment target is 100 participants.
The verdict
NCT04997304, a Phase 4 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This trial is being completed to determine baseline inhalation parameters and patterns of use in patients receiving treatment with TEVA digital inhalers, to develop predictive models for asthma exacerbations and response to biologics using data collected from these devices. Enrolled participants will complete questionnaires along with other study specific procedures. Additionally, in-person and phone visits will be performed.
Interventions
- COMBINATION_PRODUCT AirDuo Digihaler
- COMBINATION_PRODUCT ProAir Digihaler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2021-07-09 |
| Est. Completion | 2023-12-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04997304
The ClinicalTrials.gov registry entry for NCT04997304 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which AirDuo Digihaler is the first listed.
NCT04997304 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04997304 about?
NCT04997304 is a clinical study titled "Teva Asthma Predictive Analytics Study". This trial is being completed to determine baseline inhalation parameters and patterns of use in patients receiving treatment with TEVA digital inhalers, to develop predictive models for asthma exacerbations and response to biologics using data collected from these devices. Enrolled participants wi...
What is the current status of trial NCT04997304?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2021-07-09. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT04997304?
The interventions under investigation include: AirDuo Digihaler (COMBINATION_PRODUCT), ProAir Digihaler (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04997304?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.